Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Boyd

Showing results (1171-1180 of 1,228) with videos related to

Pageof 123
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic ProfilingGiuseppe Bertuglia, Elisa Seneca, Timothy Corbett, et al.
Ebiomedicine|April 29, 2021
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case seriesThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Research Square|May 19, 2023
Organoid modeling of lung-resident immune responses to SARS-CoV-2 infectionShannon S Choi, Vincent van Unen, Huimin Zhang, et al.
Journal of the American Medical Informatics Association : JAMIA|June 26, 2023
Potential bias and lack of generalizability in electronic health record data: reflections on health equity from the National Institutes of Health Pragmatic Trials CollaboratoryAndrew D Boyd, Rosa Gonzalez-Guarda, Katharine Lawrence, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunityThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Infectious Diseases and Therapy|September 4, 2022
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy AdultsVenkateshan S Prativadibhayankaram, Lawrence Soon-U Lee, David Lye, et al.
Immunity|March 30, 2023
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infectionFei Gao, Vamsee Mallajosyula, Prabhu S Arunachalam, et al.
Nature|July 31, 2025
Mouse lemur cell atlas informs primate genes, physiology and diseaseCamille Ezran, Shixuan Liu, Stephen Chang, et al.
Cell Host & Microbe|August 15, 2014
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteriaAshley M Trama, M Anthony Moody, S Munir Alam, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
VISTA-induced tumor suppression by a four amino acid intracellular motifYan Zhao, Tina Andoh, Fatima Charles, et al.
Pageof 123

Showing results (1171-1180 of 1,228) with videos related to

Sort By:
Pageof 123
Clinical Lymphoma, Myeloma & Leukemia|November 29, 2025
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic ProfilingGiuseppe Bertuglia, Elisa Seneca, Timothy Corbett, et al.
Ebiomedicine|April 29, 2021
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case seriesThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Research Square|May 19, 2023
Organoid modeling of lung-resident immune responses to SARS-CoV-2 infectionShannon S Choi, Vincent van Unen, Huimin Zhang, et al.
Journal of the American Medical Informatics Association : JAMIA|June 26, 2023
Potential bias and lack of generalizability in electronic health record data: reflections on health equity from the National Institutes of Health Pragmatic Trials CollaboratoryAndrew D Boyd, Rosa Gonzalez-Guarda, Katharine Lawrence, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunityThao T Truong, Alex Ryutov, Utsav Pandey, et al.
Infectious Diseases and Therapy|September 4, 2022
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy AdultsVenkateshan S Prativadibhayankaram, Lawrence Soon-U Lee, David Lye, et al.
Immunity|March 30, 2023
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infectionFei Gao, Vamsee Mallajosyula, Prabhu S Arunachalam, et al.
Nature|July 31, 2025
Mouse lemur cell atlas informs primate genes, physiology and diseaseCamille Ezran, Shixuan Liu, Stephen Chang, et al.
Cell Host & Microbe|August 15, 2014
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteriaAshley M Trama, M Anthony Moody, S Munir Alam, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
VISTA-induced tumor suppression by a four amino acid intracellular motifYan Zhao, Tina Andoh, Fatima Charles, et al.
Pageof 123